Cingulate (CING) Stock Chart & Stock Price History $3.83 -0.02 (-0.52%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cingulate Stock Price Performance5 Day Performance-5.20%1 Month Performance-20.37%3 Month Performance+1,198.31%6 Month Performance+297.06%Year-To-Date Performance-49.93%1 Year Performance-54.13% Receive CING Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cingulate and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW CING Stock Chart for Tuesday, November, 5, 2024 CING Chart by TradingView Cingulate Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$3.85$3.83-0.52%$3.94$3.8043,623 shs$11.66 million11/01/2024$4.04$3.85-4.70%$4.10$3.8165,808 shs$11.70 million10/31/2024$4.26$4.04-5.16%$4.29$3.95101,756 shs$12.30 million10/30/2024$4.39$4.26-2.96%$4.48$4.19105,648 shs$31.29 million10/29/2024$4.34$4.39+1.15%$4.46$4.3364,291 shs$32.25 million10/28/2024$4.37$4.34-0.69%$4.55$4.2585,914 shs$31.88 million Get the Latest News and Ratings for CING and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cingulate and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$4.63$4.37-5.62%$4.75$4.3191,006 shs$32.10 million10/24/2024$4.67$4.63-0.86%$4.79$4.5248,091 shs$34.01 million10/23/2024$5.19$4.67-10.02%$5.18$4.5295,996 shs$34.30 million10/22/2024$4.92$5.19+5.49%$5.23$4.86120,398 shs$38.12 million10/21/2024$4.59$4.92+7.19%$4.93$4.55109,679 shs$36.14 million10/18/2024$4.49$4.59+2.23%$4.60$4.4148,686 shs$33.71 million10/17/2024$4.40$4.49+2.05%$4.54$4.3527,930 shs$32.98 million10/16/2024$4.45$4.40-1.12%$4.54$4.2857,212 shs$32.32 million10/15/2024$4.51$4.45-1.33%$4.62$4.4181,778 shs$32.69 million10/14/2024$4.84$4.51-6.82%$4.97$4.44144,979 shs$33.13 million10/11/2024$4.45$4.84+8.76%$5.01$4.50195,975 shs$35.55 million10/10/2024$4.34$4.45+2.53%$4.45$4.1784,355 shs$32.69 million10/09/2024$4.50$4.34-3.56%$4.72$4.30212,056 shs$31.88 million10/08/2024$4.87$4.50-7.60%$4.94$4.50150,501 shs$33.05 million10/07/2024$4.81$4.87+1.25%$4.98$4.6787,760 shs$35.77 million10/04/2024$4.82$4.81-0.21%$4.94$4.7561,076 shs$35.33 million10/03/2024$4.81$4.82+0.21%$4.91$4.8164,107 shs$35.40 million10/02/2024$4.92$4.81-2.24%$4.96$4.7089,681 shs$35.33 million10/01/2024$5.04$4.92-2.38%$5.10$4.87101,107 shs$36.14 million09/30/2024$5.03$5.04+0.20%$5.15$4.90157,413 shs$37.02 million09/27/2024$5.14$5.03-2.14%$5.17$4.95114,009 shs$36.95 million09/26/2024$5.15$5.14-0.19%$5.29$4.96158,819 shs$37.75 million09/25/2024$5.01$5.15+2.79%$5.21$5.0556,553 shs$37.83 million09/24/2024$5.12$5.01-2.15%$5.22$4.94155,005 shs$36.80 million09/23/2024$5.20$5.12-1.54%$5.17$4.92159,616 shs$37.61 million09/20/2024$5.14$5.20+1.17%$5.44$5.07170,279 shs$38.19 million09/19/2024$4.94$5.14+4.05%$5.30$4.92281,450 shs$37.75 million09/18/2024$5.17$4.94-4.45%$5.23$4.85308,770 shs$36.28 million09/17/2024$4.95$5.17+4.44%$5.35$4.92261,697 shs$37.97 million09/16/2024$5.40$4.95-8.33%$5.48$4.92407,232 shs$36.36 million09/13/2024$5.94$5.40-9.09%$6.47$5.35608,929 shs$5.13 million09/12/2024$6.51$5.94-8.76%$6.70$5.67428,492 shs$43.63 million09/11/2024$5.45$6.51+19.45%$7.00$5.26727,603 shs$47.82 million09/10/2024$5.49$5.45-0.73%$5.75$5.02266,234 shs$5.18 millionBlackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW09/09/2024$5.92$5.49-7.26%$6.02$5.38240,700 shs$5.22 million09/06/2024$6.02$5.92-1.66%$6.29$5.30380,869 shs$43.48 million09/05/2024$6.71$6.02-10.28%$6.71$6.00566,454 shs$44.22 million09/04/2024$7.00$6.71-4.14%$7.35$6.40506,404 shs$49.29 million09/03/2024$7.89$7.00-11.28%$7.69$6.67607,825 shs$51.42 million09/02/2024$7.89$7.89$9.69$6.015.25 million shs$57.95 million08/30/2024$6.43$7.89+22.71%$9.69$6.015.22 million shs$57.95 million08/29/2024$8.00$6.43-19.63%$7.81$6.25851,647 shs$47.23 million08/28/2024$9.88$8.00-19.03%$10.09$7.77856,063 shs$58.76 million08/27/2024$10.27$9.88-3.80%$10.59$9.70385,032 shs$72.57 million08/26/2024$9.69$10.27+5.99%$11.88$9.531.97 million shs$75.43 million08/23/2024$11.34$9.69-14.55%$10.87$9.60865,878 shs$71.17 million08/22/2024$11.00$11.34+3.09%$12.40$11.001.01 million shs$83.29 million08/21/2024$13.34$11.00-17.54%$14.37$10.902.46 million shs$80.80 million08/20/2024$12.80$13.34+4.22%$15.55$9.509.90 million shs$97.98 million08/19/2024$17.69$12.80-27.64%$16.15$11.589.39 million shs$94.02 million08/16/2024$4.80$17.69+268.54%$20.83$8.71100.05 million shs$129.93 million08/15/2024$1.85$4.80+159.46%$6.80$3.80104.87 million shs$35.26 million08/14/2024$2.25$1.85-17.78%$2.36$1.80103,202 shs$13.59 million08/13/2024$2.85$2.25-21.06%$2.95$2.14205,391 shs$16.53 million08/12/2024$2.45$2.85+16.57%$3.40$2.11439,683 shs$20.93 million08/09/2024$0.24$2.45+936.02%$2.83$1.82503,902 shs$17.96 million08/08/2024$0.27$0.24-12.95%$0.27$0.21890,254 shs$1.73 million08/07/2024$0.31$0.27-11.98%$0.31$0.26743,704 shs$1.99 million08/06/2024$0.30$0.31+4.41%$0.36$0.28278,389 shs$2.26 million08/05/2024$0.31$0.30-5.21%$0.31$0.27279,985 shs$2.17 million Related Companies WVS Financial Stock Chart Trinity Biotech Stock Chart Traws Pharma Stock Chart Anixa Biosciences Stock Chart Rani Therapeutics Stock Chart Rockwell Medical Stock Chart Eliem Therapeutics Stock Chart 23andMe Stock Chart PDS Biotechnology Stock Chart Werewolf Therapeutics Stock Chart Receive CING Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cingulate and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CING) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CING Stock Alerts